BeyondSpring Inc. Research and Development Expense
BeyondSpring Inc. (BYSI) reported Research and Development Expense of $973.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14
- BeyondSpring Inc. research and development expense for the quarter ending 2026-06-30 was $973.00K, a 2.89% decline year-over-year.
- BeyondSpring Inc. research and development expense for the quarter ending 2026-03-31 was $1.08M, a 23.11% increase year-over-year.
- BeyondSpring Inc. research and development expense for the quarter ending 2025-12-31 was $1.47M, a 212.08% increase year-over-year.
- BeyondSpring Inc. research and development expense for the quarter ending 2025-09-30 was $1.04M, a 67.04% increase year-over-year.
- BeyondSpring Inc. research and development expense for fiscal 2025 was $4.39M, a 65.96% increase from fiscal 2024.
- BeyondSpring Inc. research and development expense for fiscal 2024 was $2.64M, a 63.64% decline from fiscal 2023.
- BeyondSpring Inc. research and development expense for fiscal 2023 was $7.27M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $973.00K 10-Q · filed 2026-08-14 | $2.05M 10-Q · filed 2026-08-14 | $3.52M derived: sum of 3 quarters · filed 2026-08-14 | $4.56M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $1.08M 10-Q · filed 2026-05-13 | $2.55M derived: sum of 2 quarters · filed 2026-05-13 | $3.59M derived: sum of 3 quarters · filed 2026-05-13 | $4.59M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $2.51M derived: sum of 2 quarters · filed 2026-03-25 | $3.51M derived: sum of 3 quarters · filed 2026-08-14 | $4.39M 10-K · filed 2026-03-25 | |
| 2025-09-30 | $1.04M 10-Q · filed 2025-11-12 | $2.04M derived: sum of 2 quarters · filed 2026-08-14 | $2.92M 10-Q · filed 2025-11-12 | $3.39M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $1.00M 10-Q · filed 2026-08-14 | $1.88M 10-Q · filed 2026-08-14 | $2.35M derived: sum of 3 quarters · filed 2026-08-14 | $2.97M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $874.00K 10-Q · filed 2026-05-13 | $1.35M derived: sum of 2 quarters · filed 2026-05-13 | $1.97M derived: sum of 3 quarters · filed 2026-05-13 | $2.80M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $472.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.09M derived: sum of 2 quarters · filed 2026-03-25 | $1.92M derived: sum of 3 quarters · filed 2026-03-25 | $2.64M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $622.00K 10-Q · filed 2025-11-12 | $1.45M derived: sum of 2 quarters · filed 2025-11-12 | $2.17M 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $829.00K 10-Q · filed 2025-08-13 | $1.55M 10-Q · filed 2025-08-13 | $4.15K 6-K · filed 2024-08-29 | ||
| 2024-03-31 | $721.00K 10-Q · filed 2025-05-12 | ||||
| 2023-12-31 | $7.27M 10-K · filed 2025-03-27 | ||||
| 2023-06-30 | $9.21K 6-K · filed 2024-08-29 | $9.21M 6-K · filed 2024-02-02 | |||
| 2022-12-31 | $25.58M 20-F · filed 2023-04-18 | ||||
| 2022-06-30 | $13.99M 6-K · filed 2024-02-02 | ||||
| 2021-12-31 | $5.79M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $14.24M derived: sum of 2 quarters · filed 2023-04-18 | $25.58M derived: sum of 3 quarters · filed 2023-04-18 | $36.89M 20-F · filed 2023-04-18 | |
| 2021-09-30 | $8.46M 6-K · filed 2021-12-30 | $19.79M derived: sum of 2 quarters · filed 2021-12-30 | $31.10M 6-K · filed 2021-12-30 | $39.53M derived: sum of 4 quarters · filed 2023-04-18 | |
| 2021-06-30 | $11.33M 6-K · filed 2021-09-10 | $22.64M 6-K · filed 2023-02-28 | $31.07M derived: sum of 3 quarters · filed 2023-04-18 | $39.70M derived: sum of 4 quarters · filed 2023-04-18 | |
| 2021-03-31 | $11.31M 6-K · filed 2021-06-16 | $19.73M derived: sum of 2 quarters · filed 2023-04-18 | $28.37M derived: sum of 3 quarters · filed 2023-04-18 | $39.40M derived: sum of 4 quarters · filed 2023-04-18 | |
| 2020-12-31 | $8.42M derived: 20-F 12 month − 6-K 9 month · filed 2023-04-18 | $17.06M derived: sum of 2 quarters · filed 2023-04-18 | $28.09M derived: sum of 3 quarters · filed 2023-04-18 | $41.79M 20-F · filed 2023-04-18 | |
| 2020-09-30 | $8.64M 6-K · filed 2021-12-30 | $19.66M derived: sum of 2 quarters · filed 2021-12-30 | $33.37M 6-K · filed 2021-12-30 | $45.95M derived: sum of 4 quarters · filed 2022-04-14 | |
| 2020-06-30 | $11.03M 6-K · filed 2021-09-10 | $24.73M 6-K · filed 2021-09-10 | $37.31M derived: sum of 3 quarters · filed 2022-04-14 | $44.54M derived: sum of 4 quarters · filed 2022-04-14 | |
| 2020-03-31 | $13.70M 6-K · filed 2021-06-16 | $26.28M derived: sum of 2 quarters · filed 2022-04-14 | $33.51M derived: sum of 3 quarters · filed 2022-04-14 | $38.72M derived: sum of 4 quarters · filed 2022-04-14 | |
| 2019-12-31 | $12.58M derived: 20-F 12 month − 6-K 9 month · filed 2022-04-14 | $19.81M derived: sum of 2 quarters · filed 2022-04-14 | $25.01M derived: sum of 3 quarters · filed 2022-04-14 | $31.34M 20-F · filed 2022-04-14 | |
| 2019-09-30 | $7.23M 6-K · filed 2020-11-17 | $12.43M derived: sum of 2 quarters · filed 2020-11-17 | $18.76M 6-K · filed 2020-11-17 | $31.19M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2019-06-30 | $5.20M 6-K · filed 2020-09-03 | $11.53M 6-K · filed 2020-09-03 | $23.96M derived: sum of 3 quarters · filed 2021-04-30 | $38.08M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2019-03-31 | $6.33M 6-K · filed 2020-06-11 | $18.76M derived: sum of 2 quarters · filed 2021-04-30 | $32.88M derived: sum of 3 quarters · filed 2021-04-30 | $43.87M derived: sum of 4 quarters · filed 2021-04-30 | |
| 2018-12-31 | $12.43M derived: 20-F 12 month − 6-K 9 month · filed 2021-04-30 | $26.55M derived: sum of 2 quarters · filed 2021-04-30 | $37.54M derived: sum of 3 quarters · filed 2021-04-30 | $51.62M 20-F · filed 2021-04-30 | |
| 2018-09-30 | $14.12M 6-K · filed 2019-12-18 | $25.12M derived: sum of 2 quarters · filed 2019-12-18 | $39.19M 6-K · filed 2019-12-18 | $53.90M derived: sum of 4 quarters · filed 2020-04-30 | |
| 2018-06-30 | $10.99M 6-K · filed 2019-09-18 | $25.07M 6-K · filed 2019-09-18 | $39.77M derived: sum of 3 quarters · filed 2020-04-30 | $55.06M derived: sum of 4 quarters · filed 2020-04-30 | |
| 2018-03-31 | $14.07M 6-K · filed 2019-07-10 | $28.78M derived: sum of 2 quarters · filed 2020-04-30 | $44.07M derived: sum of 3 quarters · filed 2020-04-30 | $56.26M derived: sum of 4 quarters · filed 2020-04-30 | |
| 2017-12-31 | $14.70M derived: 20-F 12 month − 6-K 9 month · filed 2020-04-30 | $29.99M derived: sum of 2 quarters · filed 2020-04-30 | $42.18M derived: sum of 3 quarters · filed 2020-04-30 | $88.93M 20-F · filed 2020-04-30 | |
| 2017-09-30 | $15.29M 6-K · filed 2017-11-09 | $27.48M derived: sum of 2 quarters · filed 2018-10-23 | $74.22M 6-K · filed 2017-11-09 | $77.25M derived: sum of 4 quarters · filed 2019-04-30 | |
| 2017-06-30 | $12.19M 6-K · filed 2018-10-23 | $58.94M 6-K · filed 2018-10-23 | $61.96M derived: sum of 3 quarters · filed 2019-04-30 | $64.70M derived: sum of 4 quarters · filed 2019-04-30 | |
| 2017-03-31 | $46.75M 6-K · filed 2018-06-21 | $49.77M derived: sum of 2 quarters · filed 2019-04-30 | $52.51M derived: sum of 3 quarters · filed 2019-04-30 | $55.70M derived: sum of 4 quarters · filed 2019-04-30 | |
| 2016-12-31 | $3.02M derived: 20-F 12 month − 6-K 9 month · filed 2019-04-30 | $5.76M derived: sum of 2 quarters · filed 2019-04-30 | $8.95M derived: sum of 3 quarters · filed 2019-04-30 | $10.44M 20-F · filed 2019-04-30 | |
| 2016-09-30 | $2.74M 6-K · filed 2017-11-09 | $5.93M derived: sum of 2 quarters · filed 2017-11-09 | $7.41M 6-K · filed 2017-11-09 | ||
| 2016-06-30 | $3.19M derived: 6-K 6 month − 6-K 3 month · filed 2017-08-21 | $4.67M 6-K · filed 2017-08-21 | |||
| 2016-03-31 | $1.49M 6-K · filed 2017-05-22 | ||||
| 2015-12-31 | $6.28M 20-F · filed 2018-04-03 | ||||
| 2014-12-31 | $1.88M 20-F · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |